About Carmustine
            
            Class: | Alkylating agent  
Use: | Treatment of certain types of brain tumors (e.g., glioblastoma multiforme), multiple myeloma, and lymphoma; also used as part of conditioning regimens prior to stem cell transplantation.  
Adult dose: | 100 mg/m² IV infusion every 6 weeks; dosage may vary based on specific indication and patient condition.  
Pediatric dose: | Not established; use in pediatric patients should be determined by a specialist based on individual circumstances.  
Side effects: | Naus
         
        
            
                
                
                    
                        Drug Class
                    
                    Alkylating agent
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of certain types of brain tumors (e.g., glioblastoma multiforme), multiple myeloma, and lymphoma; also used as part of conditioning regimens prior to stem cell transplantation.
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (20-25°C or 68-77°F); protect from light; reconstituted solution should be used immediately or stored at 2-8°C (36-46°F) for up to 24 hours.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Tillomed Laboratories Ltd., UNITED KINGDOM
                    
                    
                    Package Size
                    Vial plus Solvent
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 5922.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        100 mg/m² IV infusion every 6 weeks; dosage may vary based on specific indication and patient condition.
                    
                    
                        Pediatric Dose
                    
                    
                        Not established; use in pediatric patients should be determined by a specialist based on individual circumstances.
                    
                 
                
                
                    
                        Side Effects
                    
                    Nausea, vomiting, myelosuppression (bone marrow suppression), pulmonary toxicity, liver toxicity, and infusion site reactions.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to carmustine or any component of the formulation; severe bone marrow suppression; pregnancy and breastfeeding unless the benefits outweigh risks.
         
        
        
            
                Important Warnings
            
            Risk of severe myelosuppression leading to increased risk of infection and bleeding; potential for pulmonary toxicity; monitor lung function; use caution in patients with pre-existing lung disease.
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.